AtriCure (ATRC) News Today $38.47 +0.83 (+2.21%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period AtriCure stock soars to 52-week high, hits $39.08January 17 at 6:57 PM | msn.comAtriCure (NASDAQ:ATRC) Hits New 52-Week High - Should You Buy?AtriCure (NASDAQ:ATRC) Reaches New 52-Week High - Here's What HappenedJanuary 17 at 5:22 PM | marketbeat.comATRC Receives Buy Rating Due to Strong Financial Performance and Positive Growth ProjectionsJanuary 15 at 12:10 PM | markets.businessinsider.comAtriCure (NASDAQ:ATRC) Earns "Buy" Rating from Needham & Company LLCJanuary 15 at 3:27 AM | americanbankingnews.comJPMorgan Chase & Co. Cuts Stock Position in AtriCure, Inc. (NASDAQ:ATRC)JPMorgan Chase & Co. decreased its holdings in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 21.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 255,144 shares of the medical device companJanuary 15 at 3:19 AM | marketbeat.comAtriCure reports preliminary Q4 revenue $124.3M, consensus $119.85MJanuary 14, 2025 | markets.businessinsider.comAtriCure’s Strong Performance and Promising Outlook Justify Buy Rating Amid Competitive PressuresJanuary 14, 2025 | markets.businessinsider.comAtriCure (NASDAQ:ATRC) Shares Gap Up - Should You Buy?AtriCure (NASDAQ:ATRC) Shares Gap Up - What's Next?January 13, 2025 | marketbeat.comAtriCure's (ATRC) "Buy" Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC restated a "buy" rating and set a $40.00 price objective on shares of AtriCure in a research report on Monday.January 13, 2025 | marketbeat.comAtriCure (NASDAQ:ATRC) Issues FY 2024 Earnings GuidanceAtriCure (NASDAQ:ATRC) updated its FY 2024 earnings guidance. The company provided EPS guidance of -0.800--0.740 for the period, compared to the consensus estimate of -0.740. The company also issued revenue guidance of $465.3 millionillion-$465.3 millionillion, compared to the consensus estimate of $460.9 millionillion.January 13, 2025 | marketbeat.comAtriCure Inc (ATRC) Announces Strong Preliminary 2024 Financial Results and 2025 GuidanceJanuary 13, 2025 | gurufocus.comBrokerages Set AtriCure, Inc. (NASDAQ:ATRC) Target Price at $42.00January 12, 2025 | americanbankingnews.comAtriCure, Inc. (NASDAQ:ATRC) Given Average Rating of "Buy" by AnalystsAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) has received an average rating of "Buy" from the eight brokerages that are currently covering the firm, MarketBeat reports. Eight research analysts have rated the stock with a buy rating. The average twelve-month target price among brokers that have iJanuary 9, 2025 | marketbeat.comAtriCure (NASDAQ:ATRC) Trading 2.7% Higher - Still a Buy?AtriCure (NASDAQ:ATRC) Trading 2.7% Higher - Here's What HappenedJanuary 8, 2025 | marketbeat.comJane Street Group LLC Reduces Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)Jane Street Group LLC decreased its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 74.9% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 22,390 shares of the medical device company's stock after selling 66,943 shares during the quartJanuary 5, 2025 | marketbeat.comShort Interest in AtriCure, Inc. (NASDAQ:ATRC) Decreases By 5.3%AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) was the recipient of a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 1,600,000 shares, a drop of 5.3% from the November 30th total of 1,690,000 shares. Based on an average daily trading volume, of 508,100 shares, the days-to-cover ratio is presently 3.1 days.December 31, 2024 | marketbeat.comGeode Capital Management LLC Increases Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)Geode Capital Management LLC boosted its holdings in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 2.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,152,628 shares of the medical device company's stock aftDecember 26, 2024 | marketbeat.comAtriCure to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 23, 2024 | finance.yahoo.comBarclays PLC Decreases Position in AtriCure, Inc. (NASDAQ:ATRC)Barclays PLC decreased its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 57.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 129,265 shares of the medical device company's stock afDecember 23, 2024 | marketbeat.comState Street Corp Acquires 63,002 Shares of AtriCure, Inc. (NASDAQ:ATRC)State Street Corp raised its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 4.9% in the third quarter, according to its most recent filing with the SEC. The firm owned 1,344,856 shares of the medical device company's stock after purchasing an additional 63,002 shares during theDecember 21, 2024 | marketbeat.comAtriCure's (ATRC) "Overweight" Rating Reiterated at JPMorgan Chase & Co.JPMorgan Chase & Co. restated an "overweight" rating and set a $40.00 price target on shares of AtriCure in a research note on Tuesday.December 17, 2024 | marketbeat.comY Intercept Hong Kong Ltd Takes Position in AtriCure, Inc. (NASDAQ:ATRC)Y Intercept Hong Kong Ltd purchased a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 21,884 shares of the medical device company's stock, valued at approximDecember 15, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Orion Portfolio Solutions LLCOrion Portfolio Solutions LLC reduced its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 50.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 40,621 shares of the medical device company's stockDecember 15, 2024 | marketbeat.comBNP Paribas Financial Markets Decreases Stake in AtriCure, Inc. (NASDAQ:ATRC)BNP Paribas Financial Markets decreased its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 86.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 12,534 shares of the medical device company's stock after selling 79,020 shares duringDecember 15, 2024 | marketbeat.comAtriCure price target raised to $61 from $53 at CanaccordDecember 11, 2024 | markets.businessinsider.comFmr LLC Decreases Stock Position in AtriCure, Inc. (NASDAQ:ATRC)Fmr LLC decreased its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 53.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 973,456 shares of the medical device company's stock after sellinDecember 10, 2024 | marketbeat.comTwo Sigma Advisers LP Has $18.62 Million Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)Two Sigma Advisers LP raised its holdings in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 14.6% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 664,100 shares of the medical device company's stock after acquiring an additional 84,700 shares durinDecember 9, 2024 | marketbeat.comAtom Investors LP Makes New $1.74 Million Investment in AtriCure, Inc. (NASDAQ:ATRC)Atom Investors LP purchased a new stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 62,095 shares of the medical device company's stock, valued at approximately $1,741,000December 3, 2024 | marketbeat.comPDT Partners LLC Buys New Shares in AtriCure, Inc. (NASDAQ:ATRC)PDT Partners LLC purchased a new position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 23,701 shares of the medical device company's stock, vDecember 3, 2024 | marketbeat.comBridgewater Associates LP Sells 20,632 Shares of AtriCure, Inc. (NASDAQ:ATRC)Bridgewater Associates LP decreased its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 51.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 19,685 shares of the medical device company's stock after selling 20,6December 3, 2024 | marketbeat.comIntech Investment Management LLC Takes $427,000 Position in AtriCure, Inc. (NASDAQ:ATRC)Intech Investment Management LLC acquired a new position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 15,214 shares of the medical device compDecember 3, 2024 | marketbeat.comHealthcare of Ontario Pension Plan Trust Fund Invests $1.99 Million in AtriCure, Inc. (NASDAQ:ATRC)Healthcare of Ontario Pension Plan Trust Fund bought a new stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 71,000 shares of the medical device company's stocDecember 2, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Wasatch Advisors LPWasatch Advisors LP lowered its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 2.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 769,252 shares of the medical device company's stock aDecember 1, 2024 | marketbeat.comShort Interest in AtriCure, Inc. (NASDAQ:ATRC) Declines By 25.8%AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) saw a significant decline in short interest in November. As of November 15th, there was short interest totalling 1,670,000 shares, a decline of 25.8% from the October 31st total of 2,250,000 shares. Based on an average daily trading volume, of 567,600 shares, the short-interest ratio is presently 2.9 days.November 29, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Shares Could Be 26% Below Their Intrinsic Value EstimateNovember 28, 2024 | uk.finance.yahoo.comBNP PARIBAS ASSET MANAGEMENT Holding S.A. Raises Stake in AtriCure, Inc. (NASDAQ:ATRC)BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its holdings in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 31.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 500,649 shares of the medical device company's stockNovember 24, 2024 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Grows Position in AtriCure, Inc. (NASDAQ:ATRC)Connor Clark & Lunn Investment Management Ltd. raised its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 39.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 185,819 shares ofNovember 24, 2024 | marketbeat.comB. Metzler seel. Sohn & Co. Holding AG Makes New Investment in AtriCure, Inc. (NASDAQ:ATRC)B. Metzler seel. Sohn & Co. Holding AG bought a new position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 31,366 shares of the medical device company's stock, valuedNovember 24, 2024 | marketbeat.comAtriCure to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNovember 21, 2024 | finance.yahoo.comAtriCure, Inc. (NASDAQ:ATRC) Given Consensus Recommendation of "Buy" by BrokeragesAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) has received an average recommendation of "Buy" from the nine ratings firms that are currently covering the stock, MarketBeat.com reports. Nine analysts have rated the stock with a buy rating. The average twelve-month target price among brokers that hNovember 20, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Assetmark Inc.Assetmark Inc. reduced its holdings in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 95.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,406 shares of the medical device company's stock after seNovember 19, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Sees Significant Decrease in Short InterestAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) was the recipient of a significant decline in short interest in October. As of October 31st, there was short interest totalling 2,250,000 shares, a decline of 31.6% from the October 15th total of 3,290,000 shares. Based on an average trading volume of 586,600 shares, the days-to-cover ratio is currently 3.8 days.November 14, 2024 | marketbeat.comAtriCure to Participate in the Stifel 2024 Healthcare ConferenceNovember 8, 2024 | finance.yahoo.comEmerald Advisers LLC Acquires 38,421 Shares of AtriCure, Inc. (NASDAQ:ATRC)Emerald Advisers LLC increased its holdings in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 10.9% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 389,836 shares of the medical device company's stock afteNovember 3, 2024 | marketbeat.comUS$42.67 - That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These ResultsNovember 3, 2024 | finance.yahoo.comAtriCure Third Quarter 2024 Earnings: Beats ExpectationsNovember 1, 2024 | finance.yahoo.comAtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Market ChallengesOctober 31, 2024 | finance.yahoo.comOppenheimer Sticks to Its Buy Rating for Atricure (ATRC)October 31, 2024 | markets.businessinsider.comAtriCure (NASDAQ:ATRC) Stock Price Expected to Rise, Canaccord Genuity Group Analyst SaysCanaccord Genuity Group increased their target price on shares of AtriCure from $49.00 to $53.00 and gave the stock a "buy" rating in a research note on Wednesday.October 30, 2024 | marketbeat.comAtriCure price target raised to $36 from $32 at OppenheimerOctober 30, 2024 | msn.com Get AtriCure News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter. Email Address ATRC Media Mentions By Week ATRC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATRC News Sentiment▼0.460.44▲Average Medical News Sentiment ATRC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATRC Articles This Week▼164▲ATRC Articles Average Week Get AtriCure News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ITGR News Today IART News Today ATEC News Today OFIX News Today SRDX News Today ANGO News Today ARAY News Today RMTI News Today RSLS News Today ABT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATRC) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AtriCure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AtriCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATRC Stock Alerts